By customizing care to patients’ tumor DNA and matching them with targeted treatments, TheraMap can help improve results and reduce costs. This way, patients can spend less time worrying about treatment and enjoy a better quality of life.
The Science Behind TheraMap
How TheraMap Can Help
Cancer is caused by changes in DNA that can make a normal cell become cancerous.
Using TheraMap, Intermountain Precision Genomics will analyze your tumor DNA to discover what changes, or gene mutations, are causing your cancer and help determine what treatment could best target your advanced (stage IV) cancer.
Together, Intermountain Precision Genomics and your cancer care team will work with you to determine your unique needs, communicate and review results with you, and develop an individualized treatment plan.
Based on test results, you and your cancer care team can see whether you might benefit from traditional therapy, such as chemotherapy or radiation, targeted infusion treatments, personalized medications, or from participating in a clinical trial.
These genetically personalized treatments often improve patients’ quality of life, with medications they can take at home, keeping them out of treatment centers and enjoying life with fewer side effects than radiation and chemotherapy.
One cutting-edge treatment TheraMap could match you to is immunotherapy, a personalized infusion that boosts the body’s own immune system to fight cancer.
TheraMap uses innovative technologies to assess if your tumor is likely to respond to immunotherapy.